First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease
<a href="https://pixabay.com/users/Free-Photos/">Free-Photos</a> / Pixabay

First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

According to a story from globenewswire.com, the biopharmaceutical company Reata Pharmaceuticals, Inc. has recently announced that the company has officially enrolled its first patient in its phase 3 clinical trial.…

Continue Reading
Close Menu